Open AccessIdentification of K‐ ras Oncogene Mutations in the Pure Pancreatic Juice of Patients with Ductal Pancreatic Cancers
Author(s) -
Watanabe Hiroyuki,
Sawabu Norio,
Ohta Hideki,
Satomura Yoshitake,
Yamakawa Osamu,
Motoo Yoshiharu,
Okai Takashi,
Takahashi Hirokazu,
Wakabayashi Tokio
Publication year - 1993
Publication title -
japanese journal of cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 0910-5050
DOI - 10.1111/j.1349-7006.1993.tb00185.x
Subject(s) - pancreatic juice , pancreatic cancer , pancreatitis , mutation , oncogene , pancreatic disease , pancreas , ca19 9 , chemistry , microbiology and biotechnology , cancer , allele , cancer research , pathology , medicine , biology , gene , biochemistry , cell cycle
Pancreatic cancer is detected on the basis of morphological changes delineated by means of various image‐diagnostic methods. However, differentiation between chronic pancreatitis and pancreatic cancer, especially at the early stage, is not always simple when based upon the morphological changes alone. Therefore, we attempted to elucidate K‐ ras mutations in the sediment of pure pancreatic juice (PPJ) containing exfoliated ductal pancreatic cancer cells. PPJ was collected endoscopically from 20 patients with pancreatic cancer (PC) and 18 patients with chronic pancreatitis (CP). Polymerase chain reaction and allele specific oligonucleotide dot blot hybridization for K‐ ras mutations were performed with the DNA extracted from these samples. A K‐ ras mutation at codon 12 was identified in the PPJ of 11/20 (55%) of the patients with PC. On the other hand, the same mutation was not identified in the PPJ of any patient with CP. Moreover, K‐ ras mutations at codons 13 and 61 were not recognized in the PPJ of any patient with either PC or CP. These findings suggested that the presence of a K‐ ras mutation at codon 12 in PPJ would be useful in confirming the diagnosis of PC.